SATB2 and ovarian mucinous neoplasm: Although 30% of mucinous ovarian tumors (n = 104) had IHC performed for CK7, CK20, CDX2, SATB2, and PAX8 in a prior study (4), we were unable to perform this diagnostic panel on all cases and could not confirm whether they were done as part of routine pathologic assessment.